Omeros Announces Successful Primate Study in OncotoX-AML™ Drug Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/4/2026

1. NKE
2. USO
3. SPY
4. ACN
5. NVDA
6. LAES
7. FICO
8. TRU
9. TLT
10. WBD

Go back to Omeros Announces Successful Primate Study in OncotoX-AML™ Drug Program
Omeros Corporation (NASDAQ: OMER) Delayed: 18.61 +0.14 (0.76%)
Previous Close $18.47    52 Week High $16.80 
Open $18.60    52 Week Low $7.20 
Day High $18.76    P/E N/A 
Day Low $18.22    EPS $-1.64 
Volume 956,392